MediWound Ltd.
MDWD- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- SEC CIK
- 0001593984
In the last 90 days, MediWound Ltd. insiders filed 1 open-market purchase and 2 sales; 78 institutions reported holding it in 13F filings for Q2 2026, worth $85.5M in total; ARK Invest is the only superinvestor holding it.
Q4 2023 vs. Q3 2023
How the institutions holding MediWound Ltd. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 18 | 22 | +4 |
| Shares | 1.96M | 2.52M | +557.0K (+28.4%) |
| Value | $20.9M | $25.6M | +$4.73M (+22.7%) |
New holders (7)
Institutions that held MediWound Ltd. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Rosalind Advisors, Inc. | 606,751 | $6.17M | 5.16% |
| Silverberg Bernstein Capital Management LLC | 78,984 | $803.3K | 0.77% |
| Citadel Advisors LLC | 16,698 | $169.8K | 0.00% |
| We Are One Seven, LLC | 12,158 | $123.6K | 0.01% |
| Pathstone Holdings, LLC | 10,874 | $110.6K | 0.00% |
| Advisory Services Network, LLC | 143 | $1.45K | 0.00% |
| JPMorgan Chase & Co | 7 | $71 | 0.00% |
Sold out (3)
Institutions that held MediWound Ltd. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Alyeska Investment Group, L.P. | 127,729 | $1.36M |
| Tower Research Capital LLC (TRC) | 151 | $1.61K |
| Steward Partners Investment Advisory, LLC | 143 | $1.52K |